RheumaDATA - Rheumatology in Hamburg

Transcription

RheumaDATA - Rheumatology in Hamburg
Publikationen
RheumaDATA: Versorgungsforschung für die Rheumatoide Arthritis
Aries PM; Wassenberg S, Fliedner G, Amberger C, Vollberg C, Neuwirth J Braner A
DGRh 2015
Verträglichkeit von Tocilizumab bei jungen Erwachsenen mit einer juvenilen
idiopathischen Arthritis (JIA)
Klotsche J Niewert M; Haas JP; Aries PM; Ochs W; Zink A; Horneff; Minden K
DGRh 2015
Non-Response to Anti-Tnf Treatment in Psoriatic Arthritis Can be Predicted By
an Objective Automated Measurement of Fluorescence-Signal Intensities in
Fluorescence-Optical Imaging Technique – the First Interims Analysis of the
Xpore-Study
Michaela Koehm, Tanja Rossmanith, Ulf Henkemeier, Peer Aries, Rieke Alten, HansEckhard Lager, Harald Burkhardt, and Frank Behrens
ACR/ARHP Annual Meeting 2015
Non-Interventional Clinical Study Investigating the Use of Goliumab in Patients
with Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in
German – 3rd Interim Analysis
Matthias H. Thomas, Klaus Krüger, Peer Aries, Martin Bohl-Buehler, Jan BrandtJuergens, Verena Rickert and Siegfried Wassenberg
ACR/ARHP Meeting 2015
Sozio- und gesundheitsökonomische Parameter bei Patienten mit RA, PsA und
AS in einer nicht-interventionellen klinischen Erhebung unter Golimumab –
GO-NICE 3. Interimsanalyse
Matthias Thomas, Klaus Krüger, Peer Aries, Martin Bohl-Bühler, Jan Brandt-Jürgens,
Verena Rickert
DGRh 2015
Messung des patientenrelevanten Nutzens bei rheumatoider Arthritis und
multipler Sklerose
Christine Blome, Helen Beckmann, Christoph Heesen, Peer M. Aries, Nicolaj Witt,
Matthias Augustin
DKVF 2015
Lebensqualität von Patienten mit RA, PsA und AS in einer nichtinterventionellen klinischen Erhebung unter Golimumab – GO-NICE 3.
Interimsanalyse
Matthias Thomas, Klaus Krüger, Peer Aries, Martin Bohl-Bühler, Jan Brandt-Jürgens,
Verena Rickert
DGRh 2015
B-cell targeted therapy in patients with granulomatosis with polyangiitis and
microscopic polyangiitis
Moosig F, Aries PM, de Groot K, Hauitz M, Hellmich B, Iking-Konert C, Wagner AD,
Zänker M
Dtsch Med Wochenschr. 2014 Oct; 139/44):2248-53. Doi: 10.1055/s-0034-1387327.
Epub 2014 Oct 21. Review. German. PubMed PMID: 25334077
Vasculitis: update 2014
Fleck M, Aries PM, Iking-Konert C.
Dtsch Med Wochenschr. 2014 Jun; 139(23): 1234-6. Doi: 10.1055/s-0034-1370063.
Epub 2014 May 27. Review. German. PubMed PMID: 24866957.
Therapieentscheidungen bei RA-Patienten nach DMARD-Versagen – klinischer
Alltag vs. Therapieempfehlungen
PM. Aries, R. Dockhorn, A. Maltzahn, LG Meier, S. Petrat, U. Prothmann, C. Stille, H.
Strothmeyer, MA Vollmer
DGRh 2014
Rituximab in Rheumatoid Arthritis – 4 Years Interim Analysis oft he NonInterventional BRIDGING Study
A. Krause, P. Aries, HM. Lorenz, U. Müller-Ladner, G. Neeck, H. Rusch, J. Wendler
DGRh 2014
Nicht interventionelle Evaluierung: Klinisches Bild, Arbeitsfähigkeit und
Lebensqualität unter Golimumab – 2. Interimsanalyse GO-NICE
M. Thomas, K. Krüger, P. Aries, M. Bohl-Bühler, J. Brandt-Jürgens, V. Rickert
DGRh 2014
DUO Registry Group. Functional impairment of systemic scleroderma patients
with digital uclerations: results from the DUO Registry
Guillevin L, Hunsch E, Denton CP, Krieg T, Schwierin B, Rosenberg D, MatucciCerinic M in Vertretung der DUO-Studiengruppe
Clin Exp Rheumatol. 2013 Mar-Apr; 31 (2 Suppl 76): 71-80. Epub 2013 Jul 22.
PubMed PMID: 23910613
Rituximab in Rheumatoid Arthritits – Interim Analysis of the non-interventional
Bridging Study
A. Krause, P. M. Aries, H.-M. Lorenz, U. Müller-Ladner, G. Neeck, H. Rusch, J.
Wendler
Ann Rheum Dis 2013; 72 (Suppl3) : 445
DUO Registry investigators. Demographic, clinical and antibody characteristics
of patients with digital ulcers in systemic sclerosis: data from the DUO
Registry.
Denton CP, Krieg T, Guillevin L, Schwierin B, Rosenberg D, Silkey M, Zultak M,
Matucci-Cerinic M in Vertretung der DUO Studiengruppe
Ann Rheum Dis. 2012 May; 71(5): 718-21.
Rituximab in Rheumatoid Arthritis – Interim Analysis of the non-interventional
Bridging Study
A. Krause, P. M. Aries, H.-M. Lorenz, U. Müller-Ladner, J. Kandenwein, J. Wendler
Ann Rheuma Dis 2012; 71 (Suppl3) : 667
Tocilizumab in Rheumatoid Arthritis – One Year Interim Analysis oft he noninterventional ICHIBAN-Study
C. Specker, J. Kaufmann, M.A. Vollmer, H. Kellner, M. Bohl-Bühler, M. Aringer, A.
Alberding, H. Schwenke, C. Kühne, K. Lüthke, H. P. Tony, S. Zinke, A. Kapelle, T.
Klopsch, P. M. Aries, S. Remstedt, A. Melzer, P. Hellmann, S. Türk, G. Fliedner
Ann Rheum Dis 2012; 71 (Suppl3) : 667
GO-NICE: Interim-analysis of patients with Rheumatoid Arthritis, Ankylosing
Spondylitis or Psoriatic Arthritis treated with Golimumab in a real-life setting in
Germany
Dr. Kathrin Nickel, Dr. med. Peer Aries, Martin Bohl-Bühler, PD Dr. med. Jan BrandtJürgens, Dr. med. Ilka Schwarze, Dr. med. Silke Zinke, Dr. med. Markus Peceny
DGRh 2012
Wirksamkeit und Sicherheit einer sequentiellen Therapie mit Tocilizumab (TCZ)
und – bei zunächst inadäquater Response auf TCZ – gefolgt von Rituximab
(RTX), in DMARD-IR Patienten mit RA (MIRAI-Studie) – 1. Interimsanalyse
Prof. Dr. med. Thomas Dörner, Prof. Dr. med. Hans-Peter Tony, Prof. Dr. med.
Hendrik Schulze-Koops, Dr. med. Peer Aries, Dr. med. Sylvia Berger, Dr. med.
Werner A. Biewer, PD Dr. med. Jan Brandt-Jürgens, Prof. Dr. med. Jürgen Braun,
Dr. med. Andreas Engel, Prof. Dr. med. Martin Fleck, Dr. med. Ino Kungdo, Dr. med.
Irmgard Gürtler, Dr. Maria Höhle, Dr. med. Jörg Kaufmann, Prof. Dr. med. Herbert
Kellner, Prof. Dr. med. Andreas Krause, Prof. Dr. med. Klaus Krüger, Dr. Reiner
Kurthen, Dr. med. Thomas Neumann, Dr. med. Wolfgang Ochs, Prof. Dr. med.
Andrea Rubbert-Roth, Dr. med. Holger Schwenke, Prof. Dr. med. Christof Specker,
Dr. med. Herbert Voigt, Prof. Dr. med Peter Wagener, Dr. Sylke Wagner, Dr. Jochen
Walter, Dr. med. Siegfried Wassenberg, Dr. med. Silke Zinke, Dr. Stefan Türk, PD
Dr. med. Christof Iking-Konert
DGRh 2012
GO-NICE: Interim-analysis of patients with Rheumatoid Arthritis treated with
Golimumab in a real-life setting in Germany
Nickel K, Aries PM, Bohl-Buehler M, Brandt-Juergens J, Braunewell V, Schwarze I,
Zinke S, Peceny M
ACR 2012
Rituximab in Rheumatoid Arthritis – Interim Analysis of the Non-Interventional
Bridging Study
A. Krause, P. M. Aries, H.-M. Lorenz, U. Müller-Ladner, J. Kandenwein, J. Wendler,
Ann Rheum Dis 2012; 71 (Suppl3):667
Frühdiagnose von Vaskulitiden
B. Hellmich, P. Lamprecht, P. M. Aries, W. L. Gross
Zeitschrift für Rheumatologie 04/2012, 0.46 Impact Factor
PRESERVE-Studie Etanercept auch bei Patienten mit mittelschwerer RA
wirksam
P. M. Aries
arthritis + rheuma 3/2012
Successful use of bortezomib in a patient with systemic lupus erythematosus
and multiple myeloma
Karen Fröhlich, Julia U. Holle, Peer M. Aries, Wolfgang L. Gross, Frank Moosig
Annals oft he rheumatic diseases 12/2010, 8.11 Impact Factor
Ann Rheum Dis. 2011 Jul; 70(7): 1344-5.
Rituximab bei rheumatoider Arthritis – Zwischenanalyse der nichtinterventionellen BRIDGING-Studie
Prof. Dr. med. Andreas Krause, Dr. med. Peer Aries, Prof. Dr. Hannes-Martin Lorenz,
Profl. Dr. med Ulf Ladner, Dr. Julia Kandenwein, Dr. med. Jörg Wendler
DGRh 2009
Vasculitis. Treatment outcome parameters
Aries PM, Gause A
Z Rheumatol. 2009 Feb; 68(1):44-8.
No seasonal variation in the onset of symptoms of 445 patients with Wegener’s
granulomatosis
Aries PM, Herlyn K, Reinhold-Keller E, Latza U
Arthritis Rheum. 2008 Jun 15; 59(6):904.
Clinical images: Saddlenose deformity caused by destructive granulomatous
inflammation in Wegener’s granulomatosis
Holl-Ulrich K, Both M, Gottschlich S, Gross WL, Aries PM, Lamprecht P
Arthritis Rheum. 2008 Mar; 58(3): 834.
The low-penetrance R92Q mutation oft he tumour necrosis factor superfamily
1A geneis neither a major risk factor for Wegener’s granulomatosis nor
multiple sclerosis
Jenne DE, Aries PM, Einwächter S, Akkad AD, Wieczorek S, Lamprecht P, Gross
WL
Ann Rheum Dis. 2007 Sep; 66(9):1266-7.
Current state of biologicals in the management of systemic vasculitis
Lamprecht P, Till A, Steinmann J, Aries PM, Gross WL
Ann N Y Acad Sci. 2007 Sep; 1110:261-70. Review. PubMed PMID: 17911441
Biological therapies: New treatment options for ANCA-associated vasculitis?
Aries PM, Lamprecht P, Gross WL
Expert Opin Biol Ther. 2007 Apr; 7(4):521-33. Review. PubMed PMID: 17373903
Report on the 34th meeting of the German Clinical Immunology Workgroup,
Frankfurt
Aries PM, Witte T, Lamprecht P
Z Rheumatol. 2007 Feb; 66(1):66(1):63-4. German. PubMed PMID:17160656
A case of destructive Wegener’s granulomatosis complicated by
cytomegalovirus infection
Aries PM, Ullrich S, Gross WL
Nat Clin Pract Rheumatol. 2006 Sep; 2(9):511-5. PubMed PMID: 16951706
Balloon angioplasty of arteries of the upper extremities in patients with
extracranial giant-cell arteritis
Both M, Aries PM, Müller-Hülsbeck S, Jahnke T, Schäfer PJ, Gross WL, Heller M,
Reuter M
Ann Rheum Dis. 2006 Sep; 65(9):1124-30.
Lack of efficacy of rituximab in Wegener’s granulomatosis with refractory
granulomatous manifestations
Aries PM, Hellmich B, Voswinkel J, Both M, Nölle B, Holl-Ulrich K, Lamprecht P,
Gross WL
Ann Rheum Dis. 2006 Jul; 65(7):853-8.
Rituximab in refractory Wegener’s granulomatisis: Favorable or not?
Aries PM, Lamprecht P, Gross WL
Am J Respir Crit Care Med. 2006 Apr 1; 173(7):815-6;
Nonsystemic vasculitic neuropathy: A clinicopathological study of 22 cases
Aries PM, Gross WL
J Rheumatol. 2006 Mar; 33(3):636; author reply 636-7.
Diagnosis and therapy of ANCA-associated vasculitis
Aries PM, Hellmich B, Gross WL
Dtsch Med Wochenschr. 2006 Mar 3; 131(9):443-6.
Intravenous immunoglobulin therapy in vasculitis: Speculation or evidence?
Aries PM, Hellmich B, Gross WL
Clin Rev Allergy Immunol. 2005 Dec; 29(3):237-45.
Wegener’s granulomatosis: A view from the granulomatous side of the disease
Aries PM, Lamprecht P, Gross WL
Isr Med Assoc J. 2005 Dec; 7(12):768-73.
Vasculitis Clinical Research Consortium; OMERACT 7 Special Interest Group.
Current status of outcome measures in vasculitis: Focus on Wegener’s
granulomatosis and microscopic polyangiitis
Merkel PA, Seo P, Aries P, Neogi T, Villa-Forte A, Boers M, Cuthbertson D, Felson
DT, Hellmich B, Hoffmann GS, Jayne DR, Kallenberg CG, Krischer J, Mahr A,
Matteson EL, Specks U, Luqmani R, Stone J
Report from OMERACT 7. J Rheumatol. 2005 Dec; 32/12):2488-95.
The PTPN22 620W allele is a risc factor for Wegener’s granulomatosis
Jagiello P, Aries P, Arning L, Wagenleiter SE, Csernok E, Hellmich B, Gross WL,
Epplen JT
Arthritis Rheum. 2005 Dec; 52(12):4039-43.
Early diagnosis of vasculitides
Hellmich B, Lamprecht P, Aries PM, Gross WL
Z Rheumatol. 2005 Nov; 64(8):538-46. Review.
Symmetric polyarthritis in a patient with Churg-Strauss Syndrome
Aries PM, Reinhold-Keller E
Dtsch Med Wochenschr. 2005 Aug 19; 130(33):1871-3.
Glucocorticoids: importance in the treatment of vasculitis
Aries PM; Hellmich B, Gross WL
Z Rheumatol. 2005 Apr; 64(3): 155-61.
Periostitis as the initial manifestation of systemic vasculitis
Aries PM, Reuter M, Lamprecht P, Gross WL
Ann Rheum Dis. 2005 Feb; 64(2):329-30.
Images in clinical medicine. Destructive eye lesions in Wegener’s
granulomatosis
Aries PM, Both M
N Engl J Med. 2005 Jan 27; 352(4):392.
EURORITS: Rheumatology education in Europe under scrutiny. Preliminary
results of a European survey
Aries PM, Amital H, Lane SE
Z Rheumatol. 2004 Oct; 63(5):428-9.
High-dose intravenous azathioprine pulse treatment in refractory Wegener’s
granulomatosis
Aries PM, Hellmich B, Reinhold-Keller E, Gross WL
Rheumatology (Oxford). 2004 Oct; 43(10):1307-8.
Predicting mortality in systemic Wegener’s granulomatosis: Comment on the
article by Bligny et al
Reinhold-Keller E, Aries PM, Gross WL
Arthritis Rheum. 2004 Oct 15; 51(5):868-9;
Primary systemic vasculitides: Diagnostic pathways
Hellmich B, Voswinkel J, Aries PM, Gross WL
Dtsch Med Wochenschr. 2004 Jun 4; 129(23):1322-7. Review.
Another look at Wegener’s granulomatosis-associated pachymeningitis
Aries PM, Reinhold-Keller E, Gross WL
J Rheumatol. 2004 Apr; 31(4):825; Author reply 825-6.
Interdisciplinary rheumatology: State oft he Art in Vasculitis Summer Academy
04/05 July 2003, Bad Bramstedt
Aries PM
Z Rheumatol. 2003 Oct; 62(5):481-3.
Subcutaneous magnesium pump in a patient with combined magnesium
transport defect
Aries PM, Schubert M, Müller-Wieland D, Krone W
Dtsch Med. Wochenschr. 2000 Aug 18; 125(33):970-2.